Last $46.75 USD
Change Today +0.03 / 0.06%
Volume 2.1M
CFN On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

carefusion corp (CFN) Snapshot

Open
$47.01
Previous Close
$46.72
Day High
$47.06
Day Low
$46.55
52 Week High
09/19/14 - $47.06
52 Week Low
09/30/13 - $36.65
Market Cap
9.5B
Average Volume 10 Days
1.3M
EPS TTM
$2.14
Shares Outstanding
202.9M
EX-Date
--
P/E TM
21.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for CAREFUSION CORP (CFN)

carefusion corp (CFN) Related Businessweek News

View More BusinessWeek News

carefusion corp (CFN) Details

CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, and respiratory care. The company operates through two segments, Medical Systems and Procedural Solutions. Its primary product brands include Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela, and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite, and Texium needle-free IV infusion valves, and administration sets and accessories; PleurX, Achieve, and Temno interventional specialty products; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Jaeger and SensorMedics cardiopulmonary diagnostic equipment; Vital Signs single-use consumables for respiratory care and anesthesiology; and MedMined data mining surveillance software and analytics tools to help hospitals identify adverse drug events and healthcare associated infections. The company also offers CareFusion branded ventilation system; and Guardrails, a software application. Its primary customers include hospitals, ambulatory surgical centers, clinics, long-term care facilities, and physician offices in the United States. The company also sells its products to hospitals in approximately 130 countries. It offers its products directly to group purchasing organizations, as well as through integrated delivery networks, wholesalers, and distributors. CareFusion Corporation was incorporated in 2009 and is headquartered in San Diego, California.

16,000 Employees
Last Reported Date: 08/11/14
Founded in 2009

carefusion corp (CFN) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.2M
Chief Financial Officer
Total Annual Compensation: $543.9K
President of Medical Systems
Total Annual Compensation: $479.7K
General Counsel, Executive Vice President and...
Total Annual Compensation: $477.7K
Compensation as of Fiscal Year 2013.

carefusion corp (CFN) Key Developments

CareFusion Corporation Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-08-2014 11:05 AM

CareFusion Corporation Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-08-2014 11:05 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: James F. Hinrichs, Chief Financial Officer.

3M Co, CareFusion Corp and C.R. Bard Eyes ConvaTec From Avista Capital Partners And Nordic Capital

3M Company (NYSE:MMM), CareFusion Corporation (NYSE:CFN) and C.R. Bard Inc. (NYSE:BCR) seeks to acquires ConvaTec Inc. from its private equity owners including Avista Capital Holdings, L.P and Nordic Capital, Reuters reported citing people familiar with the matter. The deal is believed to be explored by 2015. ConvaTec Inc. would review any compelling offer that would come before 2015. ConvaTec Inc., Avista Capital Holdings, L.P, Nordic Capital, 3M Company, CareFusion Corporation and C.R. Bard Inc could not be reached for comment.

CareFusion Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2014; Provides Earnings Guidance for the Year Ending June 30, 2015

CareFusion Corporation reported unaudited consolidated earnings results for the fourth quarter and full year ended June 30, 2014. For the quarter, the company reported revenue of $1,122 million compared to $903 million a year ago. Operating Income was $194 million compared to $170 million a year ago. Income before income tax was $173 million compared to $149 million a year ago. Income from continuing operations was $140 million or $0.67 per diluted share compared to $110 million or $0.49 per diluted share a year ago. Net income was $140 million or $0.67 per diluted share compared to $109 million or $0.49 per diluted share a year ago. Adjusted income from continuing operations grew 36% from the prior year period to $164 million, or 44% to $0.79 per diluted share. Adjusted operating income was 20.2% of revenue. For the year, the company reported revenue of $3,482 million compared to $3,550 million a year ago. Operating Income was $621 million compared to $619 million a year ago. Income before income tax was $532 million compared to $543 million a year ago. Income from continuing operations was $417 million or $1.96 per diluted share compared to $389 million or $1.74 per diluted share a year ago. Net income was $417 million or $1.96 per diluted share compared to $385 million or $1.72 per diluted share a year ago. Net cash provided by operating activities was $685 million against $614 million a year ago. Additions to property and equipment was $93 million against $84 million a year ago. Additions to intangible assets was $3 million against $21 million a year ago. Adjusted income from continuing operations increased 6% from the prior year to $503 million, or 11% on a per diluted share basis to $2.36. For the year ending June 30, 2015, the company expects GAAP diluted earnings per common share from continuing operations to be $2.15 to $2.30. Adjusted diluted earnings per common share from continuing operations to be $2.60 to $2.75.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CFN:US $46.75 USD +0.03

CFN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $147.23 USD +0.35
Endo International PLC $67.70 USD +0.76
Hospira Inc $53.85 USD +0.34
Terumo Corp ¥2,637 JPY +12.00
Varian Medical Systems Inc $82.63 USD -0.10
View Industry Companies
 

Industry Analysis

CFN

Industry Average

Valuation CFN Industry Range
Price/Earnings 23.9x
Price/Sales 2.5x
Price/Book 1.8x
Price/Cash Flow 22.7x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAREFUSION CORP, please visit www.carefusion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.